HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions.

AbstractOBJECTIVES:
Osteoprotegerin (OPG) is a regulator of bone and vascular homeostasis and acts as a decoy receptor for proapoptotic TNF-related apoptosis-inducing ligand (TRAIL).
DESIGN AND METHODS:
We assessed pericardial and serum levels of OPG and TRAIL in pericardial effusions (PE) of malignant (mPE, n=24) or non-malignant (nPE, n=34) origin, and in pericardial fluid (PF, n=25) of coronary artery disease (CAD) patients by ELISA.
RESULTS:
OPG was at least 5 fold higher in PE or PF compared to serum, with a significantly higher ratio of pericardial to serum OPG in patients with mPE or nPE compared to PF (mPE vs. PF, p=0.011; nPE vs. PF, p<0.001). TRAIL was only detectable in mPE and PF. Logistic regression analysis revealed that a high ratio of pericardial to serum OPG and high TRAIL in PE were the best variable combination to predict malignancy of PE.
CONCLUSIONS:
Pericardial and systemic OPG or TRAIL are potential diagnostic tools to discriminate between malignant or benign PE.
AuthorsKonstantinos Karatolios, Sabine Pankuweit, Claudia Goettsch, Lorenz C Hofbauer, Nina Timmesfeld, Nadia Al-Fakhri, Bernhard Maisch, Michael Schoppet
JournalClinical biochemistry (Clin Biochem) Vol. 45 Issue 3 Pg. 237-42 (Feb 2012) ISSN: 1873-2933 [Electronic] United States
PMID22202560 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Osteoprotegerin
  • TNF-Related Apoptosis-Inducing Ligand
Topics
  • Demography
  • Female
  • Humans
  • Leukocyte Count
  • Logistic Models
  • Male
  • Middle Aged
  • Models, Biological
  • Osteoprotegerin (blood)
  • Pericardial Effusion (blood)
  • TNF-Related Apoptosis-Inducing Ligand (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: